Editorial · 23 Mar 2022
OtherPublished 20 Jul 2016
38th Annual VEITHsymposium
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
The 38th Annual VEITHsymposium™ was held on 16–20 November 2011 at the Hilton New York (NY, USA) and was sponsored and accredited by the Cleveland Clinic (OH, USA). At this meeting, 533 faculty members from multiple specialties presented their views on various aspects of vascular disease. More than 4200 delegates with a vascular interest from all five continents and most countries in the world attended the meeting and there were over 650 individual presentations. In addition to being presented orally, talks (with their synchronized slides) and their related panels were recorded in their entirety and will be available on a web-based version of the meeting (see [1]) for those who missed talks or wish to refresh their memory of them. On the first day of the meeting, there were six simultaneous components dealing with endovenous management of varicose veins (led by Jose Almeida, Miami Vein Center, FL, USA, and Lowell Kabnick, New York University, School of Medicine, NY, USA), hemodialysis access (led by Thomas Vesely, MO, USA, and Larry Scher, North Shore University Hospital, NY, USA), new horizons in cardiovascular surgery (led by Roy Greenberg and Bruce Lytle, Cleveland Clinc), wounds (led by Dieter Mayer, University Hospital Zurich, Switerland), and a multidisciplinary approach to stroke management (led by Allan Brook, Montefiore Medical Center, NY, USA). Although there was a great deal of interest and audience participation in the stroke management sessions, the endovenous management of varicose veins and the hemodialysis access components had the largest attendance – sometimes with standing room only audiences. There was also a linked interventional radiology meeting (AIMsymposium™) chaired by Jacob Cynamon (Montefiore Medical Center, NY, USA). In all components new findings and techniques attracted the greatest interest and generated the most excitement. Attendees could circulate through these various component meetings according to their interests. If they missed talks, most of them were captured on the web-based version of the meeting for later review. Beginning on the second day of the meeting, important areas in vascular disease were discussed in depth at multiple sessions by multiple speakers who presented their views on specific topics in 5–6 min fast-paced talks. These talks were followed by panel discussions in which audience members could discuss the presentations or ask questions. Controversial issues were raised during contentious debates or by having individuals with sharply differing opinions on a topic present their views. Although there were some simultaneous sessions, these were limited to two at a time and usually dealt with widely divergent topics. Over the last 4 days of the meeting various broad areas were discussed (Box 1). The entire program can be reviewed by accessing the VIETHsymposium website [2]. Box 1: Topics discussed during the VEITHsymposium™. There were many highlights of the meeting, among the most important were the 26 lively debates on highly controversial topics. Those on carotid stenting versus endarterectomy, the value of chimney/periscope grafts, the role of chronic cerebrospinal venous insufficiency in multiple sclerosis and the value of the multilayer stent in treating complex aneurysms were regarded as the most interesting and stimulating – probably because they contained the greatest amount of new and controversial information. Other highlights included the multiple new developments in the treatment of infrainguinal vascular disease using new interventional techniques and the rapidly evolving treatment of thoracic aortic disease and aortic dissection by endovascular means. Controversial aspects of these new treatments and techniques attracted the greatest interest, probably because they offered the greatest opportunity for interventional specialists to explore new horizons in treatment. There was particular interest in the report by Christoph Nienaber (University of Rostock, Germany) that, after 3 years of follow-up, the INSTEAD trial demonstrates improved outcomes when patients with uncomplicated type B aortic dissections were treated with stent grafts. Other areas of great interest included the transcatheter renal artery radiofrequency treatment of resistant hypertension, new methods for evaluating the risk of asymptomatic carotid plaques and new, better endovascular techniques for dealing with major venous obstruction and pulmonary emboli, including ultrasound-accelerated thrombolysis and a novel suction device that removes large clot burdens. Of course, many questions were left unanswered awaiting additional data. Thus, although the audience appreciated the cutting edge update in many areas and the airing of controversies, delegates will hopefully return to get more information and further updates in 2012 and beyond. To learn more about VEITHsymposium 2012 or how to access the VEITHsymposium 2011 on-demand library, visit [2].
Subjects
CardiologyAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Editorial · 30 Jan 2022
Announcement of 38th World Pharmacology and Therapeutics Forum, Rome, Italy on November 21-22, 2022
Other · 27 Mar 2021
2020 Conference Announcement on 38th International Conference on Dentistry & Dental Marketing
Article · 29 Sep 2020
Awards 2020 on 38th Euro Global Summit and Expo on Vaccines and Vaccination
Article · 28 Sep 2020
Market Analysis 2020 on 38th Euro Global Summit and Expo on Vaccines and Vaccination
More from this journal
The newest in Interventional Cardiology.
Article · 27 May 2026
Commentary on Stent-Induced Coronary Stenosis in a Previously Noncritical Segment Following PCI: A Case Report
Article · 24 Mar 2026
Redo arteriovenous fistula in end stage kidney disease: Risk factors and outcomes in Taiz – Yemen
Article · 23 Feb 2026
The Silent Giant : Incidental Discovery of a Large Left Atrial Myxoma
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalInterventional Cardiology
- SubjectCardiology
- BylineArticles whose byline prints “FJ Veith”
